Immunoglobulin G1 (IgG1) is a type of antibody that plays a crucial role in the immune response by recognizing and binding to specific antigens. The substance in question, anti-(human hepatocyte growth factor) is a monoclonal antibody designed to target human hepatocyte growth factor (HGF), which is involved in various physiological processes, including cell growth, tissue repair, and angiogenesis. The designation "human-mouse monoclonal SCH 900105" indicates that this antibody is a chimeric construct, combining elements from both human and mouse immunoglobulins, which enhances its therapeutic potential while minimizing immunogenicity in humans. The presence of disulfide bonds suggests that the antibody is stabilized in a dimeric form, which is typical for IgG antibodies, allowing for effective binding and neutralization of the target antigen. This specific antibody may have applications in research and therapeutic contexts, particularly in conditions where HGF plays a significant role, such as cancer and liver diseases.

Immunoglobulin G1, anti-(human hepatocyte growth factor) (human-mouse monoclonal SCH 900105 heavy chain), disulfide with human-mouse monoclonal SCH 900105 light chain, dimer

1174900-84-5: Immunoglobulin G1 (IgG1) is a type of antibody that plays a crucial role in the immune response by recognizing and binding to specific antigens. The substance in question, anti-(human hepatocyte growth factor) is a monoclonal antibody designed to target human hepatocyte growth factor (HGF), which is involved in various physiological processes, including cell growth, tissue repair, and angiogenesis. The designation "human-mouse monoclonal SCH 900105" indicates that this antibody is a chimeric construct, combining elements from both human and mouse immunoglobulins, which enhances its therapeutic potential while minimizing immunogenicity in humans. The presence of disulfide bonds suggests that the antibody is stabilized in a dimeric form, which is typical for IgG antibodies, allowing for effective binding and neutralization of the target antigen. This specific antibody may have applications in research and therapeutic contexts, particularly in conditions where HGF plays a significant role, such as cancer and liver diseases.

<p>Anti-Human HGF Monoclonal Antibody</p>

Ficlatuzumab

Ficlatuzumab is a humanized anti-HGF mAb that inhibits c-Met signaling for squamous cell carcinoma treatment.

CAS 1174900-84-5

Immunoglobulin G1, anti-(human hepatocyte growth factor) (human-mouse monoclonal SCH 900105 heavy chain), disulfide with human-mouse monoclonal SCH 900105 light chain, dimer

Ficlatuzumab

Ref: 3D-CLA1280

Ficlatuzumab

Ref: TM-T76745